Evidence map›Paper›PMID 37353954›Full record

ArticleAmerican journal of medical genetics. Part A2023

Heterozygous variants in TBCK cause a mild neurologic syndrome in humans and mice.

Divya Nair, Abdias Diaz-Rosado, Elisa Varella-Branco, Igor Ramos, Aaron Black, Rajesh Angireddy, Joseph Park, Svathi Murali, Andrew Yoon, Brianna Ciesielski and 3 more

Open access · greenAbstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. A novel mouse model of rare neurodevelopmental disorder, TBCK Syndrome.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Divya NairDepartment of Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Abdias Diaz-RosadoDepartment of Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Elisa Varella-BrancoCentro de Estudos do Genoma Humano e Células-Tronco, Universidade de São Paulo, São Paulo, Brazil.
Igor RamosCentro de Estudos do Genoma Humano e Células-Tronco, Universidade de São Paulo, São Paulo, Brazil.
Aaron BlackDepartment of Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Rajesh AngireddyDepartment of Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-9215-2209
Joseph ParkDepartment of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Svathi MuraliDepartment of Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Andrew YoonDepartment of Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Brianna CiesielskiITMAT, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania, USA.
W Timothy O'BrienITMAT, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania, USA.
Maria Rita Passos-BuenoITMAT, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania, USA.
Elizabeth BhojDepartment of Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · USUniversidade de São Paulo · BR

Funding

The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/PennP50HD105354 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI Michael Byrne Robinson · 2021 to 2026
$9.2M
The Intellectual and Developmental Disabilities Research Center at CHOP/PennU54HD086984 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI PUTT, MARY E. · 2016 to 2020
$6.3M
Mechanism of disease in TBCK-related intellectual disability syndrome, a novel neurodegenerative disorder with mTOR dysfunctionK08NS109281 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI BHOJ, ELIZABETH JOYCE · 2019 to 2021
$428k
NICHD NIH HHS P50 HD105354NICHD NIH HHS U54 HD086984NINDS NIH HHS K08 NS109281
6 · The paper itself

Abstract

TBCK-related encephalopathy is a rare pediatric neurodegenerative disorder caused by biallelic loss-of-function variants in the TBCK gene. After receiving anecdotal reports of neurologic phenotypes in both human and mouse TBCK heterozygotes, we quantified if TBCK haploinsufficiency causes a phenotype in mice and humans. Using the tbck

Indexed as

Brain DiseasesProtein Serine-Threonine KinasesAnimalsChildHeterozygoteHumansMicePhenotypeSyndromeProtein Serine-Threonine KinasesTBCK protein, humanmTORC1neurogeneticsTBCKTBCK syndrome

Identifiers

PMID37353954
PMCPMC10524953
OpenAlexW4381839056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.